Zdrowie i gospodarka · 16/03/2017

FDA Announces Revised Draft Guidance for Rifaximin Oral Tablets

The Food and Drug Administration has released a revised draft guidance for the pharmaceutical industry on the development of generic rifaximin oral tablets, outlining product-specific recommendations for bioequivalence studies to support abbreviated new drug applications.